The use of corticosteroid therapy in refractory Kawasaki patients

被引：0

作者：

Sulaiman M. Al-Mayouf

机构：

[1] King Faisal Specialist Hospital and Research Center,Rheumatology Section, Department of Pediatrics, MBC

来源：

Clinical Rheumatology | 2004年 / 23卷

关键词：

Kawasaki disease; Methylprednisolone;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We retrospectively reviewed four children with Kawasaki disease refractory to the standard therapy. Although three patients had unusual complications, all four responded to intravenous methylprednisolone. This therapy may be considered early in the treatment of selected cases of Kawasaki disease.

引用

页码：11 / 13

页数：2

共 50 条

[21] Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
Newburger, Jane W.
Sleeper, Lynn A.
McCrindle, Brian W.
Minich, L. LuAnn
Gersony, Welton
Vetter, Victoria L.
Atz, Andrew M.
Li, Jennifer S.
Takahashi, Masato
Baker, Annette L.
Colan, Steven D.
Mitchell, Paul D.
Klein, Gloria L.
Sundel, Robert P.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 663 - 675
[22] Therapeutic targets for new therapy for corticosteroid refractory asthma
Ito, Kazuhiro
Mercado, Nicolas
EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (09) : 1053 - 1067
[23] Refractory uraemic pleuropericarditis treated successfully with corticosteroid therapy
Lee, So-Young
Hong, Gi-youn
Chung, Jun Gu
Yang, Dong Ho
Kim, Hyung-Jong
CLINICAL KIDNEY JOURNAL, 2009, 2 (06): : 473 - 475
[24] Sivelestat Sodium Hydrate Treatment for Patients with Kawasaki Disease refractory to initial intravenous immunoglobulin therapy
Ebata, Ryota
Yasukawa, Kumi
Saito, Yuko
Higashi, Kouji
Takada, Nobuyuki
Takechi, Fumie
Saito, Naoki
Kobayashi, Hironobu
Shimojo, Naoki
CIRCULATION, 2015, 131
[25] Sivelestat Sodium Hydrate Treatment for Patients with Kawasaki Disease refractory to initial intravenous immunoglobulin therapy
Ebata, Ryota
Yasukawa, Kumi
Saito, Yuko
Higashi, Kouji
Takada, Nobuyuki
Takechi, Fumie
Saito, Naoki
Kobayashi, Hironobu
Shimojo, Naoki
CIRCULATION, 2015, 131
[26] Treatment of Kawasaki disease with corticosteroid
Shulman, ST
Rowley, AH
JOURNAL OF PEDIATRICS, 1996, 129 (03): : 483 - 483
[27] Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis
Friedman, Kevin G.
Gauvreau, Kimberlee
Baker, Annette
Son, Mary Beth
Sundel, Robert
Dionne, Audrey
Giorgio, Thomas
De Ferranti, Sarah
Newburger, Jane W.
ARCHIVES OF DISEASE IN CHILDHOOD, 2021, 106 (03) : 247 - +
[28] The Efficacy and Safety of Infliximab Therapy for Refractory Kawasaki Disease in Infants
Furuta, Takashi
Yasudo, Hiroki
Ohnishi, Yuji
Miyake, Akiko
Okada, Seigo
Suzuki, Yasuo
Ohga, Shouichi
Hasegawa, Shunji
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (08) : E219 - E219
[29] Kawasaki disease in newborns and infants:: refractory forms to immunoglobulin therapy
Lucron, H
Bosser, G
Lethor, JP
Sommelet, D
Feillet, F
Burger, G
Monin, P
Marçon, F
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2004, 97 (05): : 522 - 528
[30] Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy
Raman, V
Kim, J
Sharkey, A
Chatila, T
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (06) : 635 - 637

← 1 2 3 4 5 →